Market Overview: The global Irritable Bowel Syndrome (IBS) treatment market is experiencing a dynamic transformation, driven by a combination of growing patient awareness, improved diagnostic rates, and ongoing advancements in therapeutic interventions. Valued at approximately USD 3.99 billion in 2024, the market is projected to reach $7.60 billion By 2032, expanding...